Mitochondrial enhancement of cells

US8999714B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-8999714-B2
Application numberUS-201213650234-A
CountryUS
Kind codeB2
Filing dateOct 12, 2012
Priority dateOct 28, 2010
Publication dateApr 7, 2015
Grant dateApr 7, 2015

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Certain embodiments disclosed herein include, but are not limited to, at least one of compositions, methods, devices, systems, kits, or products regarding rejuvenation or preservation of stem cells. Certain embodiments disclosed herein include, but are not limited to, methods of modifying stem cells, or methods of administering modified stem cells to at least one biological tissue.

First claim

Opening claim text (preview).

What is claimed is: 1. A method of modifying a eukaryotic cell, comprising: selecting a eukaryotic cell for modification; and extracting mitochondria or mitochondrial DNA from a maternally genetically related platelet and modifying the selected eukaryotic cell by transferring the extracted mitochondria or mitochondrial DNA to the selected eukaryotic cell wherein the mitochondrial DNA of the maternally genetically related cell includes fewer mutations than the endogenous mitochon…

Assignees

Inventors

Classifications

Patent family

Related publications grouped by family.

External sources

Next steps

Free tools are coming soon. Tell us what you want to track and we'll notify you.

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US8999714B2 cover?
Certain embodiments disclosed herein include, but are not limited to, at least one of compositions, methods, devices, systems, kits, or products regarding rejuvenation or preservation of stem cells. Certain embodiments disclosed herein include, but are not limited to, methods of modifying stem cells, or methods of administering modified stem cells to at least one biological tissue.
Who is the assignee on this patent?
Searete Llc, Invention Science Fund I Llc
What technology area does this patent fall under?
Primary CPC classification G06F19/10. Mapped technology areas include Physics.
When was this patent published?
Publication date Tue Apr 07 2015 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).